Exodus Point Capital Management, LP Celldex Therapeutics, Inc. Transaction History
Exodus Point Capital Management, LP
- $14.6 Billion
- Q4 2024
A detailed history of Exodus Point Capital Management, LP transactions in Celldex Therapeutics, Inc. stock. As of the latest transaction made, Exodus Point Capital Management, LP holds 17,244 shares of CLDX stock, worth $350,225. This represents 0.0% of its overall portfolio holdings.
Number of Shares
17,244Holding current value
$350,225% of portfolio
0.0%Shares
8 transactions
Others Institutions Holding CLDX
# of Institutions
197Shares Held
69.7MCall Options Held
960KPut Options Held
675K-
Wellington Management Group LLP Boston, MA8.98MShares$182 Million0.04% of portfolio
-
Kynam Capital Management, LP Princeton, NJ5.06MShares$103 Million8.11% of portfolio
-
Black Rock Inc. New York, NY4.69MShares$95.3 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA3.88MShares$78.8 Million0.0% of portfolio
-
Eventide Asset Management, LLC Boston, MA3.75MShares$76.2 Million1.82% of portfolio
About Celldex Therapeutics, Inc.
- Ticker CLDX
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 46,772,400
- Market Cap $950M
- Description
- Celldex Therapeutics, Inc., a biopharmaceutical company, engages in developing therapeutic monoclonal and bispecific antibodies for the treatment of various diseases. Its drug candidates include antibody-based therapeutics to treat patients with inflammatory diseases and various forms of cancer. The company's clinical development programs CDX-01...